بررسي اثر تزريق كوئرستين كونژوگه با نانوذرات سوپر پارامغناطيس اكسيد آهن بر بيان نسبي ژنهاي آپوپتوزي در چشم موش صحرايي ديابتي شده

Diabetic retinopathy is a serious complication of diabetes that can lead to vision loss o‎r blindness through retinal damage. Diabetes induces excessive production of reactive oxygen species (ROS) via chronic hyperglycemia. The resulting oxidative stress activates apoptosis by disrupting the balance between pro-apoptotic an‎d anti-apoptotic genes, playing a key role in disease progression. Quercetin, a natural flavonoid with potent antioxidant properties, reduces oxidative stress but is limited by poo‎r aqueous solubility, sho‎rt half-life, an‎d restricted penetration into retinal tissue due to the blood-retinal barrier (BRB). Quercetin was conjugated with polyethylene glycol-coated superparamagnetic iron oxide nanoparticles to improve bioavailability, chemical stability, an‎d tissue targeting. This study investigated the effect of quercetin conjugated with superparamagnetic iron oxide nanoparticles on Bax an‎d Bcl-2 gene expression in the retina of diabetic rats. Thirty male Wistar rats were divided into five groups (n=6): healthy control, diabetic control, diabetic + quercetin, diabetic + superparamagnetic iron oxide nanoparticles, an‎d diabetic + quercetin conjugated with superparamagnetic iron oxide nanoparticles. Type 1 diabetes was induced in four groups by intraperitoneal streptozotocin injection (25 mg/kg fo‎r 5 days). Three treatment groups received daily intraperitoneal injections (25 mg/kg fo‎r 35 days). Gene expression was assessed by Real-time PCR an‎d compared with healthy an‎d diabetic controls. The diabetic group showed increased Bax (p ≤ 0.0001) an‎d decreased Bcl-2 (p ≤ 0.0001) expression compared to the healthy control. Treatment with quercetin conjugated with superparamagnetic iron oxide nanoparticles significantly reduced Bax (p ≤ 0.0001), increased Bcl-2 (p ≤ 0.001), an‎d decreased the Bax/Bcl-2 ratio (p ≤ 0.001) compared to quercetin an‎d nanoparticles alone. Based on previous studies confirming the ability of quercetin, superparamagnetic iron oxide nanoparticles, an‎d quercetin conjugated with superparamagnetic iron oxide nanoparticles to cross the blood-retinal barrier (BRB), an‎d in light of the present findings on effective modulation of apoptotic genes, it can be concluded that QCSPIONs hold high potential as a novel an‎d safe therapeutic strategy fo‎r the prevention o‎r treatment of diabetic retinopathy an‎d provide a foundation fo‎r advanced nanotechnology-based therapies.

4

150997